Scientists Isolate Biomarkers that Can Identify Delirium Risk and Severity (IMAGE)
Caption
Regenstrief Institute and Indiana University School of Medicine researchers have identified blood-based biomarkers associated with both delirium duration and severity in critically ill patients. An estimated 7 million hospitalized Americans suffer from the acute confusion and disorientation, characteristics of delirium, including a majority of patients in medical or surgical ICUs.
Credit
Regenstrief Institute
Usage Restrictions
None
License
Licensed content